Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.23 (
MMP
)
4,246
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a membrane-associated
MMP
that has been recently reported to have a central role in tumour cell invasion. Here we report that both the native and overexpressed recombinant forms of MT1-
MMP
are highly enriched in low-density Triton X-100-insoluble membrane domains that contain the caveolar marker protein
caveolin 1
. Moreover, the MT1-
MMP
-dependent activation of proMMP-2 induced by concanavalin A and cytochalasin D was correlated with the processing of MT1-
MMP
to its proteolytically inactive 43 kDa fragment in U-87 glioblastoma and HT-1080 fibrosarcoma tumour cell lines; this processing was also preferentially observed within the caveolar fraction. Interestingly, whereas the expression of
caveolin 1
had no effect on the MT1-
MMP
-dependent activation of proMMP-2, its co-expression with MT1-
MMP
antagonized the MT1-
MMP
-increased migratory potential of COS-7 cells. Taken together, our results provide evidence that MT1-
MMP
is preferentially compartmentalized and proteolytically processed in caveolae of cancer cells. The inhibition of MT1-
MMP
-dependent cell migration by
caveolin 1
also suggests that the localization of MT1-
MMP
to caveolin-enriched domains might have an important function in the control of its enzymic activity.
...
PMID:Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains. 1117 Oct 51